Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for BCYC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 -0.001M
March 31, 2026 -0.012M
December 31, 2025 -0.0331M
September 30, 2025 -0.001M
June 30, 2025 -0.001M
March 31, 2025 -0.002M
December 31, 2024 2.002M
September 30, 2024 -2.239M
June 30, 2024 -549.78M
March 31, 2024 -1.870M
December 31, 2023 -0.2527M
September 30, 2023 -235.64M
June 30, 2023 -12.36M
March 31, 2023 -2.743M
December 31, 2022 -5.892M
September 30, 2022 -0.1546M
June 30, 2022 -0.1937M
March 31, 2022 -0.4474M
Date Value
December 31, 2021 -190.36M
September 30, 2021 -40.66M
June 30, 2021 -133.36M
March 31, 2021 58.69M
December 31, 2020 -2.127M
September 30, 2020 -46.65M
June 30, 2020 -0.01M
March 31, 2020 -0.002M
December 31, 2019 -0.2832M
September 30, 2019 0.9079M
June 30, 2019 -59.27M
March 31, 2019 -0.0344M
December 31, 2018 -25.39M
September 30, 2018 -0.001M
June 30, 2018 0.00
March 31, 2018 0.00
December 31, 2017 0.00

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Autolus Therapeutics Plc -0.003M
Akari Therapeutics Plc -8.237M
Biodexa Pharmaceuticals Plc --
DBV Technologies SA -89.22M
Cellectis SA -0.1741M